Triclofos Sodium

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H328208

CAS#: 7246-20-0 (sodium)

Description: Triclofos Sodium, also known as Triclofos and SCH-10159, is a drug used to treat insomnia and used for sedation.


Chemical Structure

img
Triclofos Sodium
CAS# 7246-20-0 (sodium)

Theoretical Analysis

Hodoodo Cat#: H328208
Name: Triclofos Sodium
CAS#: 7246-20-0 (sodium)
Chemical Formula: C2H3Cl3NaO4P
Exact Mass: 0.00
Molecular Weight: 251.356
Elemental Analysis: C, 9.56; H, 1.20; Cl, 42.31; Na, 9.15; O, 25.46; P, 12.32

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 7246-20-0 (sodium)   306-52-5 (free acid)    

Synonym: Triclofos Sodium; SCH-10159; SCH 10159; SCH10159

IUPAC/Chemical Name: sodium 2,2,2-trichloroethyl hydrogen phosphate

InChi Key: WFKJEZKHPGDCRK-UHFFFAOYSA-M

InChi Code: InChI=1S/C2H4Cl3O4P.Na/c3-2(4,5)1-9-10(6,7)8;/h1H2,(H2,6,7,8);/q;+1/p-1

SMILES Code: ClC(Cl)(Cl)COP(O)([O-])=O.[Na+]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info: Related CAS# 7246-20-0(Triclofos Sodium) 306-52-5 (Triclofos)

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 251.36 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Radhika KP, Sreejit MS, Ramadas KT. Efficacy of midazolam as oral premedication in children in comparison to triclofos sodium. Indian J Anaesth. 2016 Jun;60(6):415-9. doi: 10.4103/0019-5049.183389. PubMed PMID: 27330204; PubMed Central PMCID: PMC4910482.

2: Fujimoto W, Matsuo-Kanda A. Multilocalized non-pigmenting fixed drug eruption caused by triclofos sodium. Eur J Dermatol. 2014 May-Jun;24(3):380-1. doi: 10.1684/ejd.2014.2314. PubMed PMID: 24721678.

3: Akaike H, Kondo E, Kono M, Kato A. [Hypnotic effects of ramelteon during electroencephalography]. No To Hattatsu. 2016 Jan;48(1):10-3. Japanese. PubMed PMID: 27012103.

4: Jackson EA, Rabbette PS, Dezateux C, Hatch DJ, Stocks J. The effect of triclofos sodium sedation on respiratory rate, oxygen saturation, and heart rate in infants and young children. Pediatr Pulmonol. 1991;10(1):40-5. PubMed PMID: 2003045.

5: Baiotti G. Comparative trial of a new hypnotic (Finorgal) with nitrazepam and triclofos sodium. J Int Med Res. 1979;7(5):383-6. PubMed PMID: 387491.

6: McRae JD, Tadros LM. Hydrolysis kinetics of the monophosphate ester triclofos sodium. J Pharm Sci. 1978 May;67(5):631-5. PubMed PMID: 25331.

7: Triclofos sodium (Triclos) for insomnia. Med Lett Drugs Ther. 1972 Oct 13;14(21):78-80. PubMed PMID: 4567567.

8: Sakai H, Kirino E, Inoue R, Arai H. Transient administration of triclofos sodium is helpful in minimizing anticonvulsants under polypharmacy. Psychiatry Clin Neurosci. 2006 Dec;60(6):776-7. PubMed PMID: 17109718.

9: Millichap JG. Electroencephalographic evaluation of triclofos sodium sedation in children. Am J Dis Child. 1972 Oct;124(4):526-7. PubMed PMID: 4638712.

10: Shahar E, Shnaps Y, Frand M. Acute triclofos poisoning in a preterm infant. Clin Pediatr (Phila). 1979 Nov;18(11):706-7. PubMed PMID: 574069.

11: Rabbette PS, Dezateux CA, Fletcher ME, Costeloe KL, Stocks J. Influence of sedation on the Hering-Breuer inflation reflex in healthy infants. Pediatr Pulmonol. 1991;11(3):217-22. PubMed PMID: 1758743.

12: Gozal D, Drenger B, Levin PD, Kadari A, Gozal Y. A pediatric sedation/anesthesia program with dedicated care by anesthesiologists and nurses for procedures outside the operating room. J Pediatr. 2004 Jul;145(1):47-52. PubMed PMID: 15238906.

13: Asami T, Suzuki H, Yazaki S, Sato S, Uchiyama M. Effects of thyroid hormone deficiency on electrocardiogram findings of congenitally hypothyroid neonates. Thyroid. 2001 Aug;11(8):765-8. PubMed PMID: 11525269.

14: Stocks J, Dezateux CA, Jackson EA, Hoo AF, Costeloe KL, Wade AM. Analysis of tidal breathing parameters in infancy: how variable is TPTEF:TE? Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 1):1347-54. PubMed PMID: 7952563.